{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T07:59:28Z","timestamp":1774425568512,"version":"3.50.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Ankylosing spondylitis (AS) is an autoimmune disease that can cause severe deformities, and the immunological patterns associated with its onset and progression remain poorly understood. Here, after recruiting healthy donors and patients in different stages, we performed single-cell RNA sequencing for peripheral blood mononuclear cells to investigate the cytotaxonomic and immunological hallmarks associated with AS onset, aggravation and remission and explore the intrinsic laws causing AS lesions. The results showed that innate antibacterial defense functions were generally enhanced in most cell types at disease onset and were negatively associated with AS severity. The abundance and exogenous antigen presentation scores of the natural killer (NK) cell subset characterized as antigen-presenting cells (APC-NK) increased during disease aggravation but decreased during remission. Generally, APC-NK abundance and their presentation scores were negatively correlated with innate defense scores for multiple cell types. CD4\n                    <jats:sup>+<\/jats:sup>\n                    effector T cell abundance and cytotoxicity, as well as the enhancement of CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell responses by HLA-DRB1\n                    <jats:sup>+<\/jats:sup>\n                    NK cells (similar to APC-NK), were associated with AS severity. The implantation of HLA-DRB1\n                    <jats:sup>+<\/jats:sup>\n                    NK cells accelerated AS-like alterations in SKG modeling mice with curdlan induction; this was blocked with CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell exhaustion. NK cell exhaustion improved the phenotypes of AS-like mice. HLA-DPB1\/DPA1 in APC-NK participated in AS aggravation by mediating antigen presentation targeting CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Overall, innate defense antigen presentation coupling drives AS lesions and different outcomes. Furthermore, the trade-off between innate defense and NK-dependent exogenous antigen presentation results in CD4\n                    <jats:sup>+<\/jats:sup>\n                    T cell activation or inactivation, thereby contributing to AS aggravation or remission; this reveals that APC-NK is a crucial factor causing ankylosing deformities.\n                  <\/jats:p>","DOI":"10.1038\/s12276-025-01619-6","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T03:02:21Z","timestamp":1769569341000},"page":"254-271","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-immunocyte transcriptomics reveal the role of natural killer cell-dependent exogenous antigen presentation in ankylosing spondylitis severity"],"prefix":"10.1038","volume":"58","author":[{"given":"Dianshan","family":"Ke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanhao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibin","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9631-4781","authenticated-orcid":false,"given":"Xiaochun","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7408-4126","authenticated-orcid":false,"given":"Changqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinshan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,28]]},"reference":[{"key":"1619_CR1","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","volume":"17","author":"D Mauro","year":"2021","unstructured":"Mauro, D. et al. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat. Rev. Rheumatol. 17, 387\u2013404 (2021).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1619_CR2","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1002\/art.42476","volume":"75","author":"K Yi","year":"2023","unstructured":"Yi, K. et al. Analysis of single-cell transcriptome and surface protein expression in ankylosing spondylitis identifies OX40\u2013positive and glucocorticoid-induced tumor necrosis factor receptor\u2013positive pathogenic Th17 cells. Arthritis Rheumatol. 75, 1176\u20131186 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1619_CR3","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/rheumatology\/kep022","volume":"48","author":"M Rudwaleit","year":"2009","unstructured":"Rudwaleit, M. et al. Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion. Rheumatology 48, 551\u2013557 (2009).","journal-title":"Rheumatology"},{"key":"1619_CR4","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1002\/art.38404","volume":"66","author":"J Bleil","year":"2014","unstructured":"Bleil, J. et al. Histomorphologic and histomorphometric characteristics of zygapophyseal joint remodeling in ankylosing spondylitis. Arthritis Rheumatol. 66, 1745\u20131754 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1619_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/ard-2022-223297","volume":"82","author":"A Ortolan","year":"2023","unstructured":"Ortolan, A. et al. Efficacy and safety of non-pharmacological and non-biological interventions: a systematic literature review informing the 2022 update of the ASAS\/EULAR recommendations for the management of axial spondyloarthritis. Ann. Rheum. Dis. 82, 142\u2013152 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR6","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1056\/NEJMc1609622","volume":"375","author":"M Rudwaleit","year":"2016","unstructured":"Rudwaleit, M., Landew\u00e9, R. & Sieper, J. Ankylosing spondylitis and axial spondyloarthritis. N. Engl. J. Med. 375, 1302\u20131303 (2016).","journal-title":"N. Engl. J. Med."},{"key":"1619_CR7","doi-asserted-by":"publisher","first-page":"581","DOI":"10.7326\/0003-4819-111-7-581","volume":"111","author":"DT Yu","year":"1989","unstructured":"Yu, D. T., Choo, S. Y. & Schaack, T. Molecular mimicry in HLA-B27-related arthritis. Ann. Intern. Med. 111, 581\u2013591 (1989).","journal-title":"Ann. Intern. Med."},{"key":"1619_CR8","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1136\/ard.58.10.598","volume":"58","author":"JH Ringrose","year":"1999","unstructured":"Ringrose, J. H. HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27? Ann. Rheum. Dis. 58, 598\u2013610 (1999).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00281-020-00833-w","volume":"43","author":"A Nakamura","year":"2021","unstructured":"Nakamura, A., Boroojeni, S. F. & Haroon, N. Aberrant antigen processing and presentation: key pathogenic factors leading to immune activation in ankylosing spondylitis. Semin. Immunopathol. 43, 245\u2013253 (2021).","journal-title":"Semin. Immunopathol."},{"key":"1619_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1136\/annrheumdis-2021-220002","volume":"80","author":"Z Li","year":"2021","unstructured":"Li, Z. et al. Tenascin-C-mediated suppression of extracellular matrix adhesion force promotes entheseal new bone formation through activation of Hippo signalling in ankylosing spondylitis. Ann. Rheum. Dis. 80, 891\u2013902 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41413-021-00140-6","volume":"9","author":"T Yu","year":"2021","unstructured":"Yu, T. et al. Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification. Bone. Res. 9, 19 (2021).","journal-title":"Bone. Res."},{"key":"1619_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-023-01906-2","volume":"21","author":"G Zheng","year":"2023","unstructured":"Zheng, G. et al. A novel Anti-ROS osteoblast-specific delivery system for ankylosing spondylitis treatment via suppression of both inflammation and pathological new bone formation. J. Nanobiotechnology. 21, 168 (2023).","journal-title":"J. Nanobiotechnology."},{"key":"1619_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1111\/jcmm.17159","volume":"26","author":"C Ren","year":"2022","unstructured":"Ren, C. et al. Single-cell RNA-seq reveals altered NK cell subsets and reduced levels of cytotoxic molecules in patients with ankylosing spondylitis. J. Cell. Mol. Med. 26, 1071\u20131082 (2022).","journal-title":"J. Cell. Mol. Med."},{"key":"1619_CR14","doi-asserted-by":"publisher","first-page":"838636","DOI":"10.3389\/fimmu.2022.838636","volume":"13","author":"S Alber","year":"2022","unstructured":"Alber, S. et al. Single cell transcriptome and surface epitope analysis of ankylosing spondylitis facilitates disease classification by machine learning. Front. Immunol. 13, 838636 (2022).","journal-title":"Front. Immunol."},{"key":"1619_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.70206","volume":"28","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. Exploring T cell and NK cell involvement in ankylosing spondylitis through single-cell sequencing. J. Cell. Mol. Med. 28, e70206 (2024).","journal-title":"J. Cell. Mol. Med."},{"key":"1619_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.759","volume":"5","author":"H Li","year":"2024","unstructured":"Li, H. et al. Comprehensive single-cell profiling of monocytes in HLA-B27-positive ankylosing spondylitis with acute anterior uveitis. MedComm 5, e759 (2024).","journal-title":"MedComm"},{"key":"1619_CR17","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu, M. et al. \u03b2-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis. Rheum. 64, 2211\u20132222 (2012).","journal-title":"Arthritis. Rheum."},{"key":"1619_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-61022-1","volume":"10","author":"F Merah-Mourah","year":"2020","unstructured":"Merah-Mourah, F., Cohen, S., Charron, D., Mooney, N. & Haziot, A. Identification of novel human monocyte subsets and evidence for phenotypic groups defined by interindividual variations of expression of adhesion molecules. Sci. Rep. 10, 4397 (2020).","journal-title":"Sci. Rep."},{"key":"1619_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.aah4573","volume":"356","author":"AC Villani","year":"2017","unstructured":"Villani, A. C. et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science 356, eaah4573 (2017).","journal-title":"Science"},{"key":"1619_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s41573-020-00092-2","volume":"20","author":"DS Lee","year":"2021","unstructured":"Lee, D. S., Rojas, O. L. & Gommerman, J. L. B cell depletion therapies in autoimmune disease: advances and mechanistic insights. Nat. Rev. Drug Discovery 20, 179\u2013199 (2021).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"1619_CR21","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/s41584-021-00741-9","volume":"18","author":"F Rosetti","year":"2022","unstructured":"Rosetti, F., Madera-Salcedo, I. K., Rodr\u00edguez-Rodr\u00edguez, N. & Crisp\u00edn, J. C. Regulation of activated T cell survival in rheumatic autoimmune diseases. Nat. Rev. Rheumatol. 18, 232\u2013244 (2022).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1619_CR22","doi-asserted-by":"publisher","first-page":"622306","DOI":"10.3389\/fimmu.2021.622306","volume":"12","author":"UC Kucuksezer","year":"2021","unstructured":"Kucuksezer, U. C. et al. The role of natural killer cells in autoimmune diseases. Front. Immunol. 12, 622306 (2021).","journal-title":"Front. Immunol."},{"key":"1619_CR23","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1093\/rheumatology\/keac391","volume":"62","author":"M Akiyama","year":"2023","unstructured":"Akiyama, M. et al. Disease-specific expansion of CD29+ IL-17RA+ T effector cells possessing multiple signalling pathways in spondyloarthritis. Rheumatology 62, 1296\u20131305 (2023).","journal-title":"Rheumatology"},{"key":"1619_CR24","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/art.39515","volume":"68","author":"A Ridley","year":"2016","unstructured":"Ridley, A. et al. Activation-induced killer cell immunoglobulin-like receptor 3DL2 binding to HLA\u2013B27 licenses pathogenic T cell differentiation in spondyloarthritis. Arthritis Rheumatol. 68, 901\u2013914 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1619_CR25","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","volume":"15","author":"DH Quaden","year":"2016","unstructured":"Quaden, D. H., De Winter, L. M. & Somers, V. Detection of novel diagnostic antibodies in ankylosing spondylitis: an overview. Autoimmun. Rev. 15, 820\u2013832 (2016).","journal-title":"Autoimmun. Rev."},{"key":"1619_CR26","doi-asserted-by":"publisher","first-page":"896","DOI":"10.7326\/0003-4819-136-12-200206180-00011","volume":"136","author":"MA Khan","year":"2002","unstructured":"Khan, M. A. Update on spondyloarthropathies. Ann. Intern. Med. 136, 896\u2013907 (2002).","journal-title":"Ann. Intern. Med."},{"key":"1619_CR27","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1136\/annrheumdis-2016-210000","volume":"76","author":"F Ciccia","year":"2017","unstructured":"Ciccia, F. et al. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Ann. Rheum. Dis. 76, 1123\u20131132 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fcimb.2021.624094","volume":"11","author":"N Alphonse","year":"2021","unstructured":"Alphonse, N., Dickenson, R. E. & Odendall, C. Interferons: tug of war between bacteria and their host. Front. Cell. Infect. Microbiol. 11, 10 (2021).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"1619_CR29","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.4049\/jimmunol.1700250","volume":"199","author":"C Odendall","year":"2017","unstructured":"Odendall, C., Voak, A. A. & Kagan, J. C. Type III IFNs are commonly induced by bacteria-sensing TLRs and reinforce epithelial barriers during infection. J. Immunol. 199, 3270\u20133279 (2017).","journal-title":"J. Immunol."},{"key":"1619_CR30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/BOR.0000000000000716","volume":"32","author":"A Berlinberg","year":"2020","unstructured":"Berlinberg, A. & Kuhn, K. A. Barrier lymphocytes in spondyloarthritis. Curr. Opin. Rheumatol. 32, 343\u2013348 (2020).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1619_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/ard-2022-223296","volume":"82","author":"S Ramiro","year":"2022","unstructured":"Ramiro, S. et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann. Rheum. Dis. 82, 19\u201334 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR32","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.0105-2896.2009.00865.x","volume":"233","author":"RA Colbert","year":"2010","unstructured":"Colbert, R. A., DeLay, M. L., Klenk, E. I. & Layh-Schmitt, G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol. Rev. 233, 181\u2013202 (2010).","journal-title":"Immunol. Rev."},{"key":"1619_CR33","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-immunol-032414-112110","volume":"33","author":"P Bowness","year":"2015","unstructured":"Bowness, P. HLA-B27. Annu. Rev. Immunol. 33, 29\u201348 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"1619_CR34","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli, A. et al. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126, 458\u2013465 (2009).","journal-title":"Immunology"},{"key":"1619_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/JLB.3RU0420-668RR","volume":"109","author":"SA Erokhina","year":"2021","unstructured":"Erokhina, S. A. et al. HLA-DR-expressing NK cells: effective killers suspected for antigen presentation. J. Leukoc. Biol. 109, 327\u2013337 (2021).","journal-title":"J. Leukoc. Biol."},{"key":"1619_CR36","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1038\/s41587-020-0505-4","volume":"38","author":"H Huang","year":"2020","unstructured":"Huang, H., Wang, C., Rubelt, F., Scriba, T. J. & Davis, M. M. Analyzing the Mycobacterium tuberculosis immune response by T-cell receptor clustering with GLIPH2 and genome-wide antigen screening. Nat. Biotechnol. 38, 1194\u20131202 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1619_CR37","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1002\/ddr.21187","volume":"75","author":"A Cauli","year":"2014","unstructured":"Cauli, A. et al. Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis. Drug. Dev. Res. 75, S15\u2013S19 (2014).","journal-title":"Drug. Dev. Res."},{"key":"1619_CR38","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.immuni.2016.07.005","volume":"45","author":"JE Boudreau","year":"2016","unstructured":"Boudreau, J. E. et al. Cell-extrinsic MHC class I molecule engagement augments human NK cell education programmed by cell-intrinsic MHC class I. Immunity 45, 280\u2013291 (2016).","journal-title":"Immunity"},{"key":"1619_CR39","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1084\/jem.173.2.439","volume":"173","author":"P Allavena","year":"1991","unstructured":"Allavena, P. et al. Molecules and structures involved in the adhesion of natural killer cells to vascular endothelium. J. Exp. Med. 173, 439\u2013448 (1991).","journal-title":"J. Exp. Med."},{"key":"1619_CR40","first-page":"5670","volume":"126","author":"YR Pan","year":"2013","unstructured":"Pan, Y. R., Tseng, W. S., Chang, P. W. & Chen, H. C. Phosphorylation of moesin by Jun N-terminal kinase is important for podosome rosette formation in Src-transformed fibroblasts. J. Cell Sci. 126, 5670\u20135680 (2013).","journal-title":"J. Cell Sci."},{"key":"1619_CR41","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/bib\/bbr042","volume":"12","author":"P Gaudet","year":"2011","unstructured":"Gaudet, P., Livstone, M. S., Lewis, S. E. & Thomas, P. D. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief. Bioinform. 12, 449\u2013462 (2011).","journal-title":"Brief. Bioinform."},{"key":"1619_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/intimm\/dxq434","volume":"22","author":"C Costantini","year":"2010","unstructured":"Costantini, C. et al. Neutrophil activation and survival are modulated by interaction with NK cells. Int. Immunol. 22, 827\u2013838 (2010).","journal-title":"Int. Immunol."},{"key":"1619_CR43","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1189\/jlb.3A0516-227R","volume":"101","author":"S Hoegl","year":"2017","unstructured":"Hoegl, S. et al. NK cells regulate CXCR2+ neutrophil recruitment during acute lung injury. J. Leukoc. Biol. 101, 471\u2013480 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"1619_CR44","first-page":"2696","volume":"110","author":"M De Smedt","year":"2007","unstructured":"De Smedt, M. et al. Notch signaling induces cytoplasmic CD3\u03f5 expression in human differentiating NK cells. Am. J. Hematol. 110, 2696\u20132703 (2007).","journal-title":"Am. J. Hematol."},{"key":"1619_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1084\/jem.175.2.361","volume":"175","author":"L Pazmany","year":"1992","unstructured":"Pazmany, L. et al. Genetic modulation of antigen presentation by HLA-B27 molecules. J. Exp. Med. 175, 361\u2013369 (1992).","journal-title":"J. Exp. Med."},{"key":"1619_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s10067-018-4388-4","volume":"38","author":"G Slobodin","year":"2019","unstructured":"Slobodin, G., Rosner, I. & Kessel, A. Dendritic cells in the pathogenesis of ankylosing spondylitis and axial spondyloarthritis. Clin. Rheumatol. 38, 1231\u20131235 (2019).","journal-title":"Clin. Rheumatol."},{"key":"1619_CR47","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","volume":"23","author":"LL Lanier","year":"2005","unstructured":"Lanier, L. L. NK cell recognition. Annu. Rev. Immunol. 23, 225\u2013274 (2005).","journal-title":"Annu. Rev. Immunol."},{"key":"1619_CR48","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.immuni.2008.11.001","volume":"29","author":"N Satoh-Takayama","year":"2008","unstructured":"Satoh-Takayama, N. et al. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29, 958\u2013970 (2008).","journal-title":"Immunity"},{"key":"1619_CR49","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.cell.2020.08.018","volume":"182","author":"P Dogra","year":"2020","unstructured":"Dogra, P. & Farber, D. L. Stealth killing by uterine NK cells for tolerance and tissue homeostasis. Cell 182, 1074\u20131076 (2020).","journal-title":"Cell"},{"key":"1619_CR50","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1111\/jcmm.15680","volume":"24","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Association of IFN-\u03b3 polymorphisms with ankylosing spondylitis risk. J. Cell. Mol. Med. 24, 10615\u201310620 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"1619_CR51","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tim.2022.08.008","volume":"31","author":"R Parthasarathy","year":"2023","unstructured":"Parthasarathy, R. et al. The microbiome in HLA-B27-associated disease: implications for acute anterior uveitis and recommendations for future studies. Trends Microbiol. 31, 142\u2013158 (2023).","journal-title":"Trends Microbiol."},{"key":"1619_CR52","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1172\/JCI9295","volume":"106","author":"MT Fiorillo","year":"2000","unstructured":"Fiorillo, M. T. et al. CD8+ T-cell autoreactivity to an HLA-B27-restricted self-epitope correlates with ankylosing spondylitis. J. Clin. Invest. 106, 47\u201353 (2000).","journal-title":"J. Clin. Invest."},{"key":"1619_CR53","doi-asserted-by":"publisher","first-page":"816005","DOI":"10.3389\/fimmu.2022.816005","volume":"13","author":"Z Wu","year":"2022","unstructured":"Wu, Z. et al. CD3+CD4\u2212CD8\u2212 (double-negative) T cells in inflammation, immune disorders and cancer. Front. Immunol. 13, 816005 (2022).","journal-title":"Front. Immunol."},{"key":"1619_CR54","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1136\/annrheumdis-2012-201404","volume":"71","author":"U Syrbe","year":"2012","unstructured":"Syrbe, U., Scheer, R., Wu, P. & Sieper, J. Differential synovial Th1 cell reactivity towards Escherichia coli antigens in patients with ankylosing spondylitis and rheumatoid arthritis. Ann. Rheum. Dis. 71, 1573\u20131576 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR55","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1136\/ard-2022-223791","volume":"82","author":"F Tavasolian","year":"2023","unstructured":"Tavasolian, F. et al. Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitis. Ann. Rheum. Dis. 82, 1429\u20131443 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR56","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1136\/ard-2022-223146","volume":"83","author":"HL Rosenzweig","year":"2024","unstructured":"Rosenzweig, H. L. et al. Card9\/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Ann. Rheum. Dis. 83, 214\u2013222 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1619_CR57","doi-asserted-by":"publisher","first-page":"1303640","DOI":"10.3389\/fimmu.2023.1303640","volume":"14","author":"S Rodolfi","year":"2024","unstructured":"Rodolfi, S., Davidson, C. & Vecellio, M. Regulatory T cells in spondyloarthropathies: genetic evidence, functional role, and therapeutic possibilities. Front. Immunol. 14, 1303640 (2024).","journal-title":"Front. Immunol."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01619-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01619-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01619-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:12:40Z","timestamp":1774419160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-025-01619-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,28]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["1619"],"URL":"https:\/\/doi.org\/10.1038\/s12276-025-01619-6","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,28]]},"assertion":[{"value":"20 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Human sample studies were approved by the ethics committee of Fujian Provincial Hospital, based on the Declaration of Helsinki (K2022-09-055). Written consent was obtained from each patient before blood collection. Animal studies were approved by the Institutional Animal Care and Use Committee of Fujian Provincial Hospital (IACUC-FPH-SL-20240220[0059]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}